Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

217 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
No antiarrhythmic effect of direct oral anticoagulants versus vitamin K antagonists in paroxysmal atrial fibrillation patients undergoing catheter ablation.
Zweiker D, Manninger M, Sieghartsleitner R, Ebner J, Pratl B, Bisping E, Lercher P, von Lewinski D, Riedlbauer R, Rohrer U, Spronk HMH, Zirlik A, Schotten U, Scherr D. Zweiker D, et al. Among authors: spronk hmh. Int J Cardiol. 2021 May 15;331:106-108. doi: 10.1016/j.ijcard.2021.01.003. Epub 2021 Jan 26. Int J Cardiol. 2021. PMID: 33508338
Distribution, genetic and cardiovascular determinants of FVIII:c - Data from the population-based Gutenberg Health Study.
Hermanns MI, Grossmann V, Spronk HM, Schulz A, Jünger C, Laubert-Reh D, Mazur J, Gori T, Zeller T, Pfeiffer N, Beutel M, Blankenberg S, Münzel T, Lackner KJ, Ten Cate-Hoek AJ, Ten Cate H, Wild PS. Hermanns MI, et al. Int J Cardiol. 2015;187:166-74. doi: 10.1016/j.ijcard.2015.03.330. Epub 2015 Mar 21. Int J Cardiol. 2015. PMID: 25828346
Hypercoagulability causes atrial fibrosis and promotes atrial fibrillation.
Spronk HM, De Jong AM, Verheule S, De Boer HC, Maass AH, Lau DH, Rienstra M, van Hunnik A, Kuiper M, Lumeij S, Zeemering S, Linz D, Kamphuisen PW, Ten Cate H, Crijns HJ, Van Gelder IC, van Zonneveld AJ, Schotten U. Spronk HM, et al. Eur Heart J. 2017 Jan 1;38(1):38-50. doi: 10.1093/eurheartj/ehw119. Epub 2016 Apr 12. Eur Heart J. 2017. PMID: 27071821
Temporal patterns and short-term progression of paroxysmal atrial fibrillation: data from RACE V.
De With RR, Erküner Ö, Rienstra M, Nguyen BO, Körver FWJ, Linz D, Cate Ten H, Spronk H, Kroon AA, Maass AH, Blaauw Y, Tieleman RG, Hemels MEW, de Groot JR, Elvan A, de Melis M, Scheerder COS, Al-Jazairi MIH, Schotten U, Luermans JGLM, Crijns HJGM, Van Gelder IC; RACE V Investigators. De With RR, et al. Europace. 2020 Aug 1;22(8):1162-1172. doi: 10.1093/europace/euaa123. Europace. 2020. PMID: 32642768 Free PMC article.
Off-target effects of oral anticoagulants - vascular effects of vitamin K antagonist and non-vitamin K antagonist oral anticoagulant dabigatran etexilate.
van Gorp RH, Dijkgraaf I, Bröker V, Bauwens M, Leenders P, Jennen D, Dweck MR, Bucerius J, Briedé JJ, van Ryn J, Brandenburg V, Mottaghy F, Spronk HMH, Reutelingsperger CP, Schurgers LJ. van Gorp RH, et al. Among authors: spronk hmh. J Thromb Haemost. 2021 May;19(5):1348-1363. doi: 10.1111/jth.15289. Epub 2021 Mar 28. J Thromb Haemost. 2021. PMID: 33687782 Free PMC article.
Different circulating biomarkers in women and men with paroxysmal atrial fibrillation: results from the AF-RISK and RACE V studies.
De With RR, Artola Arita V, Nguyen BO, Linz D, Ten Cate H, Spronk H, Schotten U, Jan van Zonneveld A, Erküner Ö, Bayón MA, Schmidt AS, Luermans JGLM, Crijns HJGM, Van Gelder IC, Rienstra M. De With RR, et al. Europace. 2022 Feb 2;24(2):193-201. doi: 10.1093/europace/euab179. Europace. 2022. PMID: 34329401 Free PMC article.
217 results